CG Oncology (CGON) Asset Utilization Ratio (2024 - 2026)
CG Oncology's (CGON) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, up 489.55% YoY from 0.0 in Q1 2025, and down 0.89% on a QoQ basis from 0.01 in Q4 2025.
Powered by 
Analysis
CG Oncology (CGON) Asset Utilization Ratio (2024 - 2026) Analysis & Trends
CG Oncology (CGON) has 3 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 489.55% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (up 489.55% YoY) and the FY2025 annual result came in at 0.01, up 118.84% from the prior year.
- Asset Utilization Ratio retreated to 0.01 in Q1 2026, from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q4 2025 to a low of 0.0 in Q2 2025.
- A 3-year average of 0.0 and a median of 0.0 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2025 — Asset Utilization Ratio slumped 35.53% — and 2026, when it jumped 489.55%.
- Tracing CGON's Asset Utilization Ratio over 3 years: stood at 0.0 in 2024, then jumped by 204.75% to 0.01 in 2025, then fell by 0.89% to 0.01 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q1 2026), 0.01 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.13 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 0.54 |
| 10 | CG Oncology | 6.55 Bn | 6.55 Bn | -2.77 Mn | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |